The Patent Finder

Terms ending in 2029

ZymoGenetics Inc.

Every in-force patent on ZymoGenetics Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,852,591Combination of Blys And/Or April Inhibition and Immunosuppressants for Treatment of Autoimmune Disease
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US 8,461,302Purification of Recombinant Human Factor XIII
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US 7,858,759Anti- ZB7H6 Antibody-Drug Conjugates
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US 8,062,876Method for Activating PRETHROMBIN-1
In force
 · High confidence
Baxter International, Inc.In forceHigh confidence
US 9,708,390Compositions and Methods for Inhibiting Pdgfrbeta and VEGF-A
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US RE48,370Levels of Bcma Protein Expression on B Cells and Use in Methods of Treating Systemic Lupus Erythematosus
In force
 · Low confidence
University of WashingtonIn forceLow confidence
US 8,956,611COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US 9,146,242Levels of Blys/April Heterotrimers in Serum and Use in Diagnostic Methods
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US 10,640,559Nucleic Acid Molecules Encoding Humanized IL-31 Monoclonal Antibodies
In force
 · High confidence
Merck Serono S/AIn forceHigh confidence
US 9,597,062Medical Devices for Delivering Fluids During Surgery and Methods for Their Use
In force
 · High confidence
Baxter International, Inc.In forceHigh confidence
2 more term ends in 2029 · Pro
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Upgrade to Pro
9 of these are in force and held by ZymoGenetics Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited